Empliciti – Elotuzumab uses, dose and side effects
Empliciti contains the active substance elotuzumab, which is a monoclonal antibody, a type of protein designed to recognize and attach to a specific target substance in the body. Elotuzumab attaches to a target protein called SLAMF7. SLAMF7 is found in large amounts on the surface of multiple myeloma cells and certain cells in the immune system (natural killer cells). When elotuzumab binds to SLAMF7 on the multiple myeloma cells or the natural killer cells, it stimulates the immune system to attack and destroy the multiple myeloma cells.
Read More